home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Webinar on How to Detect Lack of Data Integrity

  June 02, 2016  

Compliance Trainings, Online

Description :

Data are central to the development, manufacture and marketing of pharmaceuticals of all types. The renewed interest in data integrity raises questions regarding what is data integrity and how to assess it. Lack of data integrity comes in two forms: purposeful manipulation of the data to deceive and the inadvertent problems that occur in the production and analysis of data. Humans, equipment or both can be the source of the problem. This session discusses both types of data integrity sources and introduces the assessment of “data pedigree” as a concept that puts focus on the types of data integrity issues and analytical and statistical methods for detecting data problems.  Pharma and biotech case studies are used throughout the presentation to illustrate how the various approaches together.

Areas Covered in the Session :

What is data integrity; what does it look like

Case studies illustrating types and sources of data integrity issues

Procedures for assessing data pedigree, integrity and quality

Computer, analytical and statistical methods for evaluating data integrity and quality

Limitations of observational data

Guiding principles, tips and traps for the effective data integrity assessment

Who Will Benefit:

Senior management

Quality Assurance Team Members

Quality Control Team Members

Compliance Auditors

Process Development Team Members

Supply Chain and Logistics Managers

Regulatory Affairs Team Members

Engineering Staff


IT Management and Staff working in regulated areas

Organized by: Compliance Trainings
Invited Speakers:

Ronald D. Snee, PhD, is Founder and President of Snee Associates, a firm dedicated to the successful implementation of process and organizational improvement initiatives. He provides guidance to senior executives in their pursuit of improved business performance using Quality by Design, Lean Six Sigma and other improvement approaches that produce bottom line results. Prior to his consulting career he spent 24 years at the DuPont Company in a variety of assignments including pharmaceuticals.

Deadline for Abstracts: 2016-06-13

For more information about this event please visit



E-mail: suzzane.d@compliancetrainings.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.